Product
Dexycu
Name
Dexycu
INN Name
dexamethasone
FDA Approved
Yes
3 clinical trials
1 organization
2 indications
1 document
Indication
CataractIndication
InflammationClinical trial
A Phase 3, Prospective, Randomized, Double-masked, Placebo-controlled, Parallel-design, Multicenter Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract SurgeryStatus: Withdrawn, Estimated PCD: 2023-09-01
Clinical trial
A Phase 3, Prospective, Randomized, Double-masked, Placebo-controlled, Parallel-design, Multicenter Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract SurgeryStatus: Not yet recruiting, Estimated PCD: 2024-04-01
Clinical trial
A Phase 3,Prospective, Randomized, Double-masked, Placebo-controlled, Parallel Study to Evaluate the Efficacy, PK and Safety of 9% Dexamethasone Intraocular Injection for the Treatment of Inflammation Associatedwith Cataract SurgeryStatus: Completed, Estimated PCD: 2023-11-24
Document
DailyMed Label: DexycuOrganization
EyePoint Pharmaceuticals US, Inc